Cargando…
Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers
Age represents the major risk factor for fatal disease outcome in coronavirus disease (COVID-19) due to age-related changes in immune responses. On the one hand lymphocyte counts continuously decline with advancing age, on the other hand somatic hyper-mutations of B-lymphocytes and levels of class-s...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862708/ https://www.ncbi.nlm.nih.gov/pubmed/36702013 http://dx.doi.org/10.1016/j.jiph.2023.01.016 |
_version_ | 1784875156542324736 |
---|---|
author | Pirabe, Anita Schrottmaier, Waltraud C. Heber, Stefan Schmuckenschlager, Anna Treiber, Sonja Pereyra, David Santol, Jonas Pawelka, Erich Traugott, Marianna Schörgenhofer, Christian Seitz, Tamara Karolyi, Mario Jilma, Bernd Resch, Ulrike Zoufaly, Alexander Assinger, Alice |
author_facet | Pirabe, Anita Schrottmaier, Waltraud C. Heber, Stefan Schmuckenschlager, Anna Treiber, Sonja Pereyra, David Santol, Jonas Pawelka, Erich Traugott, Marianna Schörgenhofer, Christian Seitz, Tamara Karolyi, Mario Jilma, Bernd Resch, Ulrike Zoufaly, Alexander Assinger, Alice |
author_sort | Pirabe, Anita |
collection | PubMed |
description | Age represents the major risk factor for fatal disease outcome in coronavirus disease (COVID-19) due to age-related changes in immune responses. On the one hand lymphocyte counts continuously decline with advancing age, on the other hand somatic hyper-mutations of B-lymphocytes and levels of class-switched antibodies diminish, resulting in lower neutralizing antibody titers. To date the impact of age on immunoglobulin G (IgG) production in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is unknown. Therefore, we investigated the impact of age on the onset of IgG production and its association with outcome, viral persistence, inflammatory and thrombotic markers in consecutive, hospitalized COVID-19 patients admitted to the Clinic Favoriten (Vienna, Austria) between April and October 2020 that fulfilled predefined inclusion criteria. Three different IgGs against SARS-CoV-2 (spike protein S1, nucleocapsid (NC), and the spike protein receptor binding domain (RBD)) were monitored in plasma of 97 patients upon admission and three times within the first week followed by weekly assessment during their entire hospital stay. We analyzed the association of clinical parameters including C-reactive protein (CRP), D-dimer levels and platelet count as well as viral persistence with the onset and concentration of different anti-SARS-CoV-2 specific IgGs. Our data demonstrate that in older individuals anti-SARS-CoV-2 IgG production increases earlier after symptom onset and that deceased patients have the highest amount of antibodies against SARS-CoV-2 whereas intensive care unit (ICU) survivors have the lowest titers. In addition, anti-SARS-CoV-2 IgG concentrations are not associated with curtailed viral infectivity, inflammatory or thrombotic markers, suggesting that not only serological memory but also other adaptive immune responses are involved in successful viral killing and protection against a severe COVID-19 infection. |
format | Online Article Text |
id | pubmed-9862708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98627082023-01-23 Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers Pirabe, Anita Schrottmaier, Waltraud C. Heber, Stefan Schmuckenschlager, Anna Treiber, Sonja Pereyra, David Santol, Jonas Pawelka, Erich Traugott, Marianna Schörgenhofer, Christian Seitz, Tamara Karolyi, Mario Jilma, Bernd Resch, Ulrike Zoufaly, Alexander Assinger, Alice J Infect Public Health Article Age represents the major risk factor for fatal disease outcome in coronavirus disease (COVID-19) due to age-related changes in immune responses. On the one hand lymphocyte counts continuously decline with advancing age, on the other hand somatic hyper-mutations of B-lymphocytes and levels of class-switched antibodies diminish, resulting in lower neutralizing antibody titers. To date the impact of age on immunoglobulin G (IgG) production in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is unknown. Therefore, we investigated the impact of age on the onset of IgG production and its association with outcome, viral persistence, inflammatory and thrombotic markers in consecutive, hospitalized COVID-19 patients admitted to the Clinic Favoriten (Vienna, Austria) between April and October 2020 that fulfilled predefined inclusion criteria. Three different IgGs against SARS-CoV-2 (spike protein S1, nucleocapsid (NC), and the spike protein receptor binding domain (RBD)) were monitored in plasma of 97 patients upon admission and three times within the first week followed by weekly assessment during their entire hospital stay. We analyzed the association of clinical parameters including C-reactive protein (CRP), D-dimer levels and platelet count as well as viral persistence with the onset and concentration of different anti-SARS-CoV-2 specific IgGs. Our data demonstrate that in older individuals anti-SARS-CoV-2 IgG production increases earlier after symptom onset and that deceased patients have the highest amount of antibodies against SARS-CoV-2 whereas intensive care unit (ICU) survivors have the lowest titers. In addition, anti-SARS-CoV-2 IgG concentrations are not associated with curtailed viral infectivity, inflammatory or thrombotic markers, suggesting that not only serological memory but also other adaptive immune responses are involved in successful viral killing and protection against a severe COVID-19 infection. The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2023-03 2023-01-21 /pmc/articles/PMC9862708/ /pubmed/36702013 http://dx.doi.org/10.1016/j.jiph.2023.01.016 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Pirabe, Anita Schrottmaier, Waltraud C. Heber, Stefan Schmuckenschlager, Anna Treiber, Sonja Pereyra, David Santol, Jonas Pawelka, Erich Traugott, Marianna Schörgenhofer, Christian Seitz, Tamara Karolyi, Mario Jilma, Bernd Resch, Ulrike Zoufaly, Alexander Assinger, Alice Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers |
title | Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers |
title_full | Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers |
title_fullStr | Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers |
title_full_unstemmed | Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers |
title_short | Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers |
title_sort | immunoglobulin g production in covid-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862708/ https://www.ncbi.nlm.nih.gov/pubmed/36702013 http://dx.doi.org/10.1016/j.jiph.2023.01.016 |
work_keys_str_mv | AT pirabeanita immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT schrottmaierwaltraudc immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT heberstefan immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT schmuckenschlageranna immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT treibersonja immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT pereyradavid immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT santoljonas immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT pawelkaerich immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT traugottmarianna immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT schorgenhoferchristian immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT seitztamara immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT karolyimario immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT jilmabernd immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT reschulrike immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT zoufalyalexander immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers AT assingeralice immunoglobulingproductionincovid19associationswithageoutcomeviralpersistenceinflammationandprothromboticmarkers |